日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Synergistic Effects of Viruses and Environmental Gradients on Carbon Cycling in a River Ecosystem

病毒和环境梯度对河流生态系统碳循环的协同效应

Luo, Rongxu; Deng, Hanchen; Lin, Senjie; Bo, Jun; Kong, Weijing; Wang, Shuhang; Wang, Shuping

Decision conflict, psychological resilience, and financial toxicity in early-stage non-small cell lung cancer in China: A latent profile and mediation analysis

中国早期非小细胞肺癌患者的决策冲突、心理韧性和经济毒性:潜在类别和中介分析

Liu, Man; Lv, Zhuoheng; Xing, Shujun; Yi, Hang; Wang, Lulu; Wang, Shuhang; Liu, Lu; Li, Ning

Glycemic Variability as a Predictor of Mortality in Sepsis Patients With Concurrent Persistent Inflammation, Immunosuppression, and Catabolism Syndrome

血糖变异性作为脓毒症合并持续性炎症、免疫抑制和分解代谢综合征患者死亡率的预测指标

Wang, Shuhang; Liu, Li; Li, Bowen; Liu, Yancun; Chai, Yanfen

Practical guideline for rhabdomyosarcoma in children and adolescents

儿童和青少年横纹肌肉瘤实用指南

Zhao, Guo; Ma, Peiwen; Cai, Yuanting; Jian, Aiwen; Sun, Liangjie; Wang, Shuhang; Li, Ning

Clinical diagnosis and treatment for well-differentiated liposarcoma: A clinical practice guideline

高分化脂肪肉瘤的临床诊断和治疗:临床实践指南

Cai, Yuanting; Fang, Yuan; Zhao, Guo; Wang, Yuning; Ding, Jiatong; Wang, Shuhang; Li, Ning

Recent advances in universal chimeric antigen receptor T cell therapy

通用嵌合抗原受体T细胞疗法的最新进展

Jiang, Ning; Yang, Zhaoyi; Miao, Huilei; Xing, Shujun; Wang, Shuhang; Li, Ning

Phase 1, open-label, multicenter, dose escalation safety and tolerability study of oncolytic virus OVV-01 in advanced solid tumors

溶瘤病毒OVV-01治疗晚期实体瘤的I期、开放标签、多中心、剂量递增安全性和耐受性研究

Hua, Yingqi; Wang, Chongren; Li, Fan; Han, Yanjie; Zuo, Dongqing; Lv, Yu; Sun, Mengxiong; Yuan, Peng; Yuan, Ruirong; Zhang, Fan; Ma, Liang; Wang, Yan; Wu, Hui; Zhou, Guoqing; Lin, Qiang; Wang, Shuhang; Li, Ning; Lu, Yinying

Overcoming the quality gap in clinical trial landscape analysis: Paving the way for impactful research

克服临床试验格局分析中的质量差距:为具有影响力的研究铺平道路

Wang, Yuning; Wang, Shuhang; Li, Ning

Navigating the digital health landscape from artificial intelligence-driven molecular subtyping towards optimized rare sarcoma trial design

从人工智能驱动的分子分型到优化的罕见肉瘤试验设计,引领数字健康领域发展

Wang, Yuning; Wang, Shuhang; Li, Ning

Immune cell metabolism in cancer drug resistance: Advances in target discovery and clinical translation

癌症耐药性中的免疫细胞代谢:靶点发现和临床转化进展

Sun, Liangjie; Zhao, Guo; Wang, Shuhang; Li, Ning